Inspire Medical Systems, Inc.

INSP trades at a remarkably depressed 8.77 P/E for a medical device company, yet its 28.7 RSI signals deeply oversold conditions that could set up a volatile snap-back. The 13.15% short interest suggests meaningful squeeze potential if sentiment shifts, though the stock sits well below its 52-week high—implying either fundamental deterioration or broader market skepticism toward the sector. The valuation-to-momentum disconnect creates tactical tension: it's attractive on a multiple basis but technically screaming capitulation, which can either precede relief rallies or confirm weakness if the shorting reflects genuine conviction about execution challenges or market saturation in sleep apnea devices.